Growth Factor Independence 1 (GFI1) is a transcriptional repressor that plays a critical role during both myeloid and lymphoid haematopoietic lineage commitment. Several studies have demonstrated the involvement of GFI1 in haematological malignancies and have suggested that low expression of GFI1 is a negative indicator of disease progression for both myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). In this study, we have stratified AML patients into those defined as having a normal karyotype (CN-AML). Unlike the overall pattern in AML, those patients with CN-AML have a poorer survival rate when GFI1 expression is high. In this group, high GFI1 expression is paralleled by higher FLT3 expression, and, even when the FLT3 gene is not mutated, exhibit a FLT3-ITD signature of gene expression. Knock-down of GFI1 expression in the human AML Fujioka cell line led to a decrease in the level of FLT3 RNA and protein and to the down regulation of FLT3-ITD signature genes, thus linking two major prognostic indicators for AML.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593973PMC
http://dx.doi.org/10.1038/s41598-017-11718-8DOI Listing

Publication Analysis

Top Keywords

gfi1 expression
16
flt3-itd signature
12
high gfi1
8
normal karyotype
8
aml patients
8
gfi1
7
expression
7
aml
6
prognostic significance
4
significance high
4

Similar Publications

Article Synopsis
  • Cochlear hair cells are damaged by loud sounds, certain drugs, and aging, leading to irreversible hearing loss since they don't regenerate in mammals.
  • Research has shown that using a combination of three specific hair cell transcription factors can reprogram adjacent supporting cells into hair cell-like cells, particularly after inducing damage to the existing hair cells.
  • The reprogrammed cells displayed key characteristics of mature hair cells and remained responsive to reprogramming efforts for at least 6 weeks after damage, indicating potential for hearing restoration in chronically deaf individuals.
View Article and Find Full Text PDF
Article Synopsis
  • - Gfi1 is a crucial transcriptional repressor involved in blood cell development, mainly working through its SNAG domain to recruit the histone demethylase LSD1, affecting gene regulation.
  • - The study reveals Gfi1's ability to enhance the expression of the Hemgn gene via a specific promoter region, with interactions from transcription factors like Ikaros (which activates Hemgn) and PU.1 (which represses it).
  • - Gfi1's upregulation of Hemgn not only occurs through repression of PU.1 but also contributes to Gfi1's protective role against cell death caused by stress, independent of the p53 protein.
View Article and Find Full Text PDF

Enhancing metastatic colorectal cancer prediction through advanced feature selection and machine learning techniques.

Int Immunopharmacol

December 2024

Research Center of Health Big Data Mining and Applications, School of Medical Information, Wannan Medical College, Wuhu, Anhui, China. Electronic address:

Background And Aims: Colorectal cancer (CRC) is the third most prevalent cancer globally, posing a significant challenge due to its high rate of metastasis. Approximately 20% of patients with CRC present with distant metastases at diagnosis, and over 50% develop metastases within five years. Accurate prediction of metastasis is crucial for improving survival outcomes in patients with CRC.

View Article and Find Full Text PDF

Calcitriol, the bioactive form of vitamin D, exerts its biological functions by binding to its cognate receptor, the vitamin D receptor (VDR). The indicators of the severity of allergies and asthma have been linked to low vitamin D levels. However, the role of calcitriol in regulating IL-4 and IL-13, two cytokines pivotal to allergic inflammation, remained unclear.

View Article and Find Full Text PDF

Knockdown of in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance.

Front Biosci (Landmark Ed)

July 2024

Liver Gall Bladder and Pancreatic Surgery Ward, Qinghai Red Cross Hospital, 810001 Xining, Qinghai, China.

Background: The gene is a gemcitabine (GEM) resistance gene; however, the mechanism by which it regulates GEM resistance in pancreatic cancer remains unclear.

Methods: The cell line was treated with GEM and then stimulated with . Subsequently, we constructed GEM-resistant pancreatic cancer cell lines, knocked down in these cell lines, and detected changes in the proliferation and apoptosis of drug-resistant cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!